Dr. Mark Haas, M.D.
Pathology (Anatomic Pathology & Clinical Pathology Physician)
8700 Beverly Blvd
Los Angeles, CA 90048
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Duke University School of Medicine (1982)
- Years since graduation
- 44
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 135
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1982Medical school: Duke University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Anatomic Pathology & Clinical Pathology Physician primary
MD license D55055
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cedars-Sinai Medical Center Los Angeles, CA
- Scripps Memorial Hospital La Jolla La Jolla, CA
- Torrance Memorial Medical Center Torrance, CA
- Scripps Green Hospital La Jolla, CA
- Providence St. Joseph Hospital Orange, CA
Medical groups
- Cedars-Sinai Medical Care Foundation (1,692 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 135
- Services billed
- 2,034
- Patients’ average age
- 66
| Service | Times | Patients |
|---|---|---|
| Antibody evaluation, each additional single antibody stain procedure | 837 | 93 |
| Special stained specimen slides to examine tissue including interpretation and report | 318 | 100 |
| Pathology examination of tissue using a microscope, intermediate complexity | 111 | 94 |
| Antibody evaluation, initial single antibody stain procedure | 98 | 93 |
| Electron microscopy for diagnosis | 88 | 83 |
| Special stained specimen slides to examine tissue, initial procedure | 29 | 27 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 6 companies reported 43 payments worth $80,448 in total to this clinician.
| Consulting Fee | $63,943 |
|---|---|
| Travel and Lodging | $15,093 |
| Food and Beverage | $1,412 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation Feb 28, 2025 | Consulting Fee | $13,900 |
| AstraZeneca UK Limited Jul 30, 2025 | Consulting Fee SAPHNELO · Inflammation and Autoimmunity | $13,725 |
| Argenx US, Inc. Oct 28, 2025 | Travel and Lodging VYVGART HYTRULO · Neurology · travel to Aalsmeer, Netherlands | $11,862 |
| AstraZeneca UK Limited Dec 30, 2025 | Consulting Fee SAPHNELO · Inflammation and Autoimmunity | $11,025 |
| Argenx US, Inc. Nov 20, 2025 | Consulting Fee | $9,788 |
| AstraZeneca UK Limited Apr 2, 2025 | Consulting Fee SAPHNELO · Inflammation and Autoimmunity | $8,775 |
| Otsuka America Pharmaceutical, Inc. Mar 26, 2025 | Consulting Fee | $6,018 |
| Novartis Pharmaceuticals Corporation Feb 28, 2025 | Travel and Lodging travel to JERSEY CITY, NJ · in-kind | $501 |
| Otsuka America Pharmaceutical, Inc. Feb 23, 2025 | Travel and Lodging travel to SCOTTSDALE, AZ · in-kind | $489 |
| Argenx US, Inc. May 28, 2025 | Consulting Fee | $475 |
All 25 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca UK Limited Dec 30, 2025 | Consulting Fee SAPHNELO · Inflammation and Autoimmunity | $11,025 |
| Argenx US, Inc. Nov 20, 2025 | Consulting Fee | $9,788 |
| Argenx US, Inc. Oct 28, 2025 | Travel and Lodging VYVGART HYTRULO · Neurology · travel to Aalsmeer, Netherlands | $11,862 |
| Argenx US, Inc. Oct 28, 2025 | Travel and Lodging VYVGART HYTRULO · Neurology · travel to Aalsmeer, Netherlands | $370 |
| Argenx US, Inc. Oct 28, 2025 | Travel and Lodging VYVGART HYTRULO · Neurology · travel to Aalsmeer, Netherlands | $118 |
| Argenx US, Inc. Oct 28, 2025 | Travel and Lodging VYVGART HYTRULO · Neurology · travel to Aalsmeer, Netherlands | $75.00 |
| Travere Therapeutics, Inc. Oct 24, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $409 |
| Travere Therapeutics, Inc. Oct 24, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $64.39 |
| Travere Therapeutics, Inc. Oct 24, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $12.64 |
| Travere Therapeutics, Inc. Oct 11, 2025 | Travel and Lodging travel to Minneapolis, MN · in-kind | $240 |
| AstraZeneca UK Limited Jul 30, 2025 | Consulting Fee SAPHNELO · Inflammation and Autoimmunity | $13,725 |
| Argenx US, Inc. May 28, 2025 | Consulting Fee | $475 |
| Argenx US, Inc. May 21, 2025 | Consulting Fee | $238 |
| AstraZeneca UK Limited Apr 2, 2025 | Consulting Fee SAPHNELO · Inflammation and Autoimmunity | $8,775 |
| Otsuka America Pharmaceutical, Inc. Mar 26, 2025 | Consulting Fee | $6,018 |
| Otsuka America Pharmaceutical, Inc. Mar 26, 2025 | Travel and Lodging travel to LOS ANGELES, CA | $53.50 |
| Otsuka America Pharmaceutical, Inc. Mar 26, 2025 | Travel and Lodging travel to SCOTTSDALE, AZ | $43.66 |
| Otsuka America Pharmaceutical, Inc. Mar 26, 2025 | Travel and Lodging travel to PHOENIX, AZ | $32.90 |
| Novartis Pharmaceuticals Corporation Feb 28, 2025 | Consulting Fee | $13,900 |
| Novartis Pharmaceuticals Corporation Feb 28, 2025 | Travel and Lodging travel to JERSEY CITY, NJ · in-kind | $501 |
| Novartis Pharmaceuticals Corporation Feb 28, 2025 | Travel and Lodging travel to JERSEY CITY, NJ | $139 |
| Novartis Pharmaceuticals Corporation Feb 28, 2025 | Travel and Lodging travel to JERSEY CITY, NJ · in-kind | $52.83 |
| Novartis Pharmaceuticals Corporation Feb 27, 2025 | Travel and Lodging Fabhalta · Immunology · travel to Jersey City, NJ · in-kind | $373 |
| Otsuka America Pharmaceutical, Inc. Feb 25, 2025 | Travel and Lodging travel to SCOTTSDALE, AZ · in-kind | $257 |
| Otsuka America Pharmaceutical, Inc. Feb 23, 2025 | Travel and Lodging travel to SCOTTSDALE, AZ · in-kind | $489 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.